References
- NCI Monograph 7, R E Wittes. Bethesda National Cancer Institute. 1988
- Jönsson G, Högberg B. Treatment of advanced prostatic carcinoma with Estracyt. Scand J Urol Nephrol 1971; 5: 103–7
- Anderson L, Edsmyr F, Jönsson G, Könyves T. Estramustine phosphate therapy in carcinoma of the prostate. Recent Results Cancer Res 1977; 60: 73–7
- Nagel R, Kölln C-P. Treatment of advanced carcinoma of the prostate with Estracyt. Br J Urol 1977; 49: 73–9
- Gerdes J, Schwab U, Lemke H, Stein H. Cell cycle analysis of a cell proliferation-associated nuclear antigen defined by the monoclonal antibody Ki-67. J Immunol 1984; 133: 1710–5
- Gerdes J, Dallenbach F, Lennert K. Growth fractions in malignant non-Hodgkin's lymphomas (NHL) as determined in situ with the monoclonal antibody Ki-67. Hamatol Oncol 1984; 2: 365–71
- Stone K R, Mickey D D, Wunderli H, Mickey G H, Paulson DF. Isolation of a human prostate carcinoma cell line (DU-145). Int J Cancer 1978; 21: 274–81
- Sternberger LA. Immunocytochemistry2nd edition. John Wiley and Sons. 1979; 104–69
- Freiha F S, Pistenma D A, Bagshaw MA. Pelvic lymphadenectomy for staging of prostatic carcinoma: Is it always necessary?. J Urol 1979; 122: 176–7
- Carlton CR, Jr, Dawoud F, Hudgins P, Scott R, Jr. Irradiation treatment of carcinoma of the prostate: A preliminary report based on 8 years experience. J Urol 1972; 18: 924–7